Equivalent Haloperidol Dose to Droperidol 2.5 mg
Based on available evidence, haloperidol 5 mg administered intramuscularly or intravenously is approximately equivalent to droperidol 2.5 mg for sedation and agitation management.
Dosing Equivalence Rationale
The evidence suggests a 2:1 ratio (haloperidol:droperidol) for comparable clinical effect:
- Multiple guidelines consistently cite droperidol 1.25-2.5 mg as the standard dose for sedation 1, 2, 1, 2
- Haloperidol 5-10 mg is the typical comparator dose used in clinical studies 3, 4
- Direct comparative research demonstrates that haloperidol 5 mg and droperidol 5 mg produce similar sedation times (median 20 vs 25 minutes, p=0.89), suggesting droperidol is approximately twice as potent milligram-per-milligram 5
- A 1984 study directly compared haloperidol 5 mg vs droperidol 5 mg IM, finding droperidol more effective (only 36% requiring redosing vs 81% with haloperidol), further supporting droperidol's greater potency 4
Practical Dosing Guidance
For droperidol 2.5 mg equivalent:
- Haloperidol 5 mg IM or slow IV is the appropriate starting dose
- FDA-approved maximum initial droperidol dose is 2.5 mg 6
- Haloperidol starting doses in guidelines range from 0.5-10 mg, with 5 mg being standard for acute agitation 7, 8
Dose adjustments:
- Older/frail patients: Use haloperidol 0.5-1 mg (equivalent to droperidol 0.25-0.5 mg) 7
- Pediatric patients: Haloperidol 0.1 mg/kg corresponds to droperidol 0.1 mg/kg 6
Critical Safety Considerations
Both medications carry significant risks:
- QTc prolongation: Both agents prolong QTc interval; droperidol has FDA black-box warning 1, 2
- Contraindications: Avoid in QTc >440 ms (males) or >450 ms (females), congestive heart failure, hypokalemia, hypomagnesemia, age ≥65 years, alcohol abuse 1, 2
- Extrapyramidal symptoms: Haloperidol causes more EPS than droperidol 7, 5, 9
- Hypotension: Both cause hypotension (24% with droperidol in large series) 1, 2
- Respiratory depression: Particularly when combined with benzodiazepines 10
Monitoring requirements:
- ECG monitoring essential, especially with IV administration 7
- Vital signs every 5-15 minutes initially
- Avoid in Parkinson's disease or Lewy body dementia (haloperidol) 7
Clinical Context Differences
Droperidol advantages:
- Faster onset (3-10 minutes vs 10-20 minutes for haloperidol) 1, 2
- Shorter duration (2-4 hours vs 6-8 hours) 1, 2
- Lower EPS rates 5, 9
- More effective initial sedation requiring fewer repeat doses 4, 11
Haloperidol advantages:
- No FDA black-box warning (though QTc risk remains)
- More widely available since droperidol warning
- Lower cost
- More extensive safety data in older adults 10, 12
Important caveat: Recent geriatric data shows benzodiazepines (especially midazolam) combined with antipsychotics significantly increase adverse events in older adults (OR 10.69 for respiratory events), suggesting monotherapy is safer 10. The combination of haloperidol/lorazepam showed slower sedation than droperidol/midazolam but may be safer in older populations 13.